EUVIMEDEUVIMED entdecken
Crossref

A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice

Eva Conde iD, Emma Lamanna iD, Aurélie Mougel iD, Jasper B J Kamphuis iD, Alexia Loste iD, Julien Stackowicz, Ophélie Godon iD, Emilie Mauré iD, Cyprien Pecalvel iD, William P M Worrall iD, Léna Andrieux iD, Edouard Leveque iD und 20 weitere

Science Translational Medicine · 2025

DOI: 10.1126/scitranslmed.ads0982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Eva Conde und 31 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, INSERM UMR1222, Antibodies in Therapy and Pathology, 75015 Paris, France. Hauptthemen laut MEDLINE: Anaphylaxis, Immunoglobulin E, Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: H2020 European Research Council, Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin E (IgE) antibodies play a key role in allergy and its most dangerous and life-threatening manifestation, anaphylaxis. Anti-IgE monoclonal antibodies (mAbs) have been developed to treat IgE-dependent diseases such as allergic asthma, food allergy, and chronic spontaneous urticaria. However, their use is still restricted to a minority of patients suffering from the most severe symptoms because treatment is costly and requires repeated administration. Therefore, we developed a conjugate vaccine against human IgE as a potential alternative therapy for long-term protection from IgE-dependent diseases. The IgE conjugate vaccine was generated by coupling a mutated fragment containing the Cε3-4 domains of human IgE with the carrier protein diphtheria cross-reactive material 197 (CRM 197 ) using kinoid technology to raise autoantibodies against a self-antigen by engrafting it onto the highly immunogenic CRM 197 carrier. To assess the efficacy of IgE-kinoid (IgE-K) vaccination, we generated a mouse model humanized for IgE and its high-affinity receptor FcεRI. IgE-K vaccination induced long-term production of anti–human IgE neutralizing antibodies without any detectable adverse effect. Anti-IgE antibodies were detected in the sera of IgE-K–immunized mice for up to 12 months postvaccination with a similar avidity as the approved anti-IgE mAb omalizumab. Furthermore, IgE-K vaccination protected against both IgE-mediated cutaneous and severe systemic anaphylaxis in IgE/FcεRI-humanized mice. Our results demonstrate that long-term reduction in IgE activity can be achieved through vaccination with human kinoids and can protect against anaphylaxis in humanized mice. This may represent a cost-effective, long-term therapeutic strategy for the treatment of IgE-mediated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaphylaxisImmunoglobulin EVaccinesAnimalsHumansMiceAntibodies, NeutralizingVaccinationBacterial Proteins

Substanzen

Immunoglobulin EVaccinesAntibodies, NeutralizingCRM197 (non-toxic variant of diphtheria toxin)Bacterial Proteins

Autor:innen und Institutionen

  • Institut Pasteur, Université Paris Cité, INSERM UMR1222, Antibodies in Therapy and Pathology, 75015 Paris, France.
  • Neovacs SA, 92150 Suresnes, France.
  • Sorbonne Université, College Doctoral, 75006 Paris, France.
  • University of Toulouse, Infinity, Inserm, CNRS, 31024 Toulouse, France.
  • Institut Fédératif de Biologie, University Hospital Centre of Toulouse, 31024 Toulouse, France.
  • Institut Pasteur, Université Paris Cité, CNRS UMR3569, Unité de Virologie Structurale, 75015 Paris, France.

ORCID-Profile: Eva Conde, Emma Lamanna, Aurélie Mougel, Jasper B J Kamphuis, Alexia Loste, Ophélie Godon, Emilie Mauré, Cyprien Pecalvel, William P M Worrall, Léna Andrieux, Edouard Leveque, Zohra Benmessaoud, Pol-André Apoil, Marija Backovic, Bruno Iannascoli, Jonathan Bonnefoy, Fabien Colaone, Friederike Jönsson, Patrick England, Laurent Guilleminault, Frédéric Fiore, Lara Linnemann, Minka Breloer, Nicolas Gaudenzio, Katia Lemdani, Vincent Serra, Pierre Bruhns, Laurent L Reber

Förderung

  • H2020 European Research Council
  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale
  • French National 482 Infrastructure for mouse Phenogenomicse et de la Technologie
  • Association Nationale de la Recherche et de la Technologie

Zitieren

APA

Conde, E., Lamanna, E., Mougel, A., Kamphuis, J. B. J., Loste, A., Stackowicz, J., Godon, O., Mauré, E., Pecalvel, C., Worrall, W. P. M., Andrieux, L., Leveque, E., Benmessaoud, Z., Apoil, P. A., Backovic, M., Iannascoli, B., Bonnefoy, J., Hamdi, S., Colaone, F., …, & Reber, L. L. (2025). A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ads0982

Vancouver

Conde E, Lamanna E, Mougel A, Kamphuis JBJ, Loste A, Stackowicz J, et al. A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.ads0982

BibTeX
@article{Conde2025,
  author = {Conde, Eva and Lamanna, Emma and Mougel, Aurélie and Kamphuis, Jasper B J and Loste, Alexia and Stackowicz, Julien and Godon, Ophélie and Mauré, Emilie and Pecalvel, Cyprien and Worrall, William P M and Andrieux, Léna and Leveque, Edouard and Benmessaoud, Zohra and Apoil, Pol-André and Backovic, Marija and Iannascoli, Bruno and Bonnefoy, Jonathan and Hamdi, Samir and Colaone, Fabien and Jönsson, Friederike and England, Patrick and Guilleminault, Laurent and Malissen, Bernard and Fiore, Frédéric and Linnemann, Lara and Breloer, Minka and Gaudenzio, Nicolas and Drouet, Béatrice and Lemdani, Katia and Serra, Vincent and Bruhns, Pierre and Reber, Laurent L},
  title = {A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice},
  journal = {Science Translational Medicine},
  year = {2025},
  doi = {10.1126/scitranslmed.ads0982}
}
Kostenlos starten →